미국의 복벽 헤르니아 메시 디바이스 시장 규모, 점유율, 동향 분석 보고서 : 메시 유형별, 적응증별, 수기별, 최종 용도별, 부문 예측(2025-2030년)

Market Size & Trends:

The U.S. ventral hernia mesh devices market size was estimated at USD 356.7 million in 2024 and is projected to grow at a CAGR of 8.27% from 2025 to 2030. The increasing cases of hernias, technological advancements in mesh repair, a shift towards preventive healthcare, growing preference for minimally invasive procedures, and a growing healthcare infrastructure are the factors affecting market growth. According to the U.S. FDA, over a million hernia repair procedures are performed annually in the U.S.

Hernia repair is one of the most common surgical procedures worldwide. The incidence of hernia is higher in men than in women. According to the International Journal of Surgery, approximately 300,000 ventral hernia repairs are performed annually. Among these, 75% are primary ventral hernia repairs (mainly epigastric and umbilical) and 25% are incisional hernia repairs. Furthermore, incisional hernias are common in nearly 10-30% of patients in the U.S. who undergo midline laparotomies. The annual costs for hernia repairs are estimated at approximately USD 3.2 billion. This is viewed as a major healthcare challenge for patients and a significant financial hurdle for the U.S. healthcare system.

The presence of favorable reimbursement scenarios for hernia mesh devices is encouraging patients to opt for surgery. The government and industry players provide patients with easy access to detailed reimbursement codes and ratios. The codes are granulated into types of hernias (primary or recurrent) and surgery methods (open or laparoscopic).

Technological advancements in hernia mesh devices have significantly improved patient outcomes and reduced complications. One notable innovation is the development of lightweight and composite meshes. These meshes, such as Parietex Composite Mesh, combine absorbable and nonabsorbable materials, providing strength while reducing postoperative discomfort and the risk of chronic pain. These advancements include innovations like Deep Blue Medical Advances, Inc.'s advanced mesh technology. In 2024, the company launched a smaller version of the T-Line Mesh, known as the T-Line Mini, tailored for umbilical hernias and small defects. Moreover, the T-Line Hernia Mesh's coated and biosynthetic composite versions are developing.

U.S. Ventral Hernia Mesh Devices Market Report Segmentation

This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the U.S. ventral hernia mesh devices market report based on mesh type, indication, procedure, and end use:

• Mesh Type Outlook (Revenue, USD Million, 2018 - 2030)
• Resorbable Mesh
• Partially Absorbable Mesh
• Non-resorbable Mesh
• Indication Outlook (Revenue, USD Million 2018 - 2030)
• Umbilical Hernia
• Epigastric Hernia
• Incisional Hernia
• Others
• Procedure Outlook (Revenue, USD Million 2018 - 2030)
• Open Surgery
• Laparoscopic Surgery
• Robotic Surgery
• Others
• End Use Outlook (Revenue, USD Million 2018 - 2030)
• Inpatient Facilities
• Outpatient Facilities

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Mesh Type
  • 1.2.2. Indication
  • 1.2.3. Procedure
  • 1.2.4. End Use
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in the U.S.
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Mesh Type outlook
  • 2.2.2. Indication outlook
  • 2.2.3. Procedure outlook
  • 2.2.4. End-use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. U.S. Ventral Hernia Mesh Devices Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market Driver Analysis
    • 3.1.1.1. Global Shift Toward Preventive Healthcare
    • 3.1.1.2. Supportive Government Policies
    • 3.1.1.3. Increasing Incidence of Hernias
    • 3.1.1.4. Technological Advancements in Mesh Repair
    • 3.1.1.5. Growing Preference for Minimally Invasive Procedures
  • 3.1.2. Market Restraint Analysis
    • 3.1.2.1. Complications Related to Mesh Implants
    • 3.1.2.2. High Costs of Advanced Meshes
    • 3.1.2.3. Product Recalls
• 3.2. U.S. Ventral Hernia Mesh Devices Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's
    • 3.2.1.1. Bargaining power of suppliers
    • 3.2.1.2. Bargaining power of buyers
    • 3.2.1.3. Threat of substitutes
    • 3.2.1.4. Threat of new entrants
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental Landscape
    • 3.2.2.6. Legal Landscape

Chapter 4. U.S. Ventral Hernia Mesh Devices Market: Mesh Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Ventral Hernia Mesh Devices Market: Mesh Type Movement Analysis
• 4.3. U.S. Ventral Hernia Mesh Devices Market by Mesh Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Resorbable Mesh
  • 4.5.1. Resorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Partially Absorbable Mesh
  • 4.6.1. Partially Absorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Non-resorbable Mesh
  • 4.7.1. Non-resorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Ventral Hernia Mesh Devices Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Ventral Hernia Mesh Devices Market: Indication Movement Analysis
• 5.3. U.S. Ventral Hernia Mesh Devices Market by Indication Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Umbilical Hernia
  • 5.5.1. Umbilical Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Epigastric Hernia
  • 5.6.1. Epigastric Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Incisional Hernia
  • 5.7.1. Incisional Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Ventral Hernia Mesh Devices Market: Procedure Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Ventral Hernia Mesh Devices Market: Procedure Movement Analysis
• 6.3. U.S. Ventral Hernia Mesh Devices Market by Procedure Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Open Surgery
  • 6.5.1. Open Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Laparoscopic Surgery
  • 6.6.1. Laparoscopic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Robotic Surgery
  • 6.7.1. Robotic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Ventral Hernia Mesh Devices Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Ventral Hernia Mesh Devices Market: End-use Movement Analysis
• 7.3. U.S. Ventral Hernia Mesh Devices Market by End-use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Inpatient Facilities
  • 7.5.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Outpatient Facilities
  • 7.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Company Market Position Analysis, 2024
• 8.3. Key Company Profiles
  • 8.3.1. Medtronic plc
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Becton, Dickinson and Company
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Ethicon Inc. (Johnson & Johnson MedTech)
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Meril Life Sciences Pvt. Ltd.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Novus Scientific AB
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. B. Braun SE
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. TELA Bio, Inc.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. BG Medical LLC
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Integra LifeSciences Corporation
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. W. L. Gore & Associates, Inc.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Atrium Medical
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives